Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient care LONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch report, identifying eleven therapies expected to deliver significant clinical impact and strong commercial potential over the coming year. The annual analysis highlights therapies expected to reshape treatment approaches across metabolic disease, oncology, immunology, rare conditions and neurological disorders, with the potential to achieve blockbuster status or transform care within five years.

PRNewsWire • Jan 6, 2026

Wall Street Breakfast Podcast: DHS Calls Out Hilton Over ICE

Hilton (HLT) shares fell nearly 2.5% after DHS accused a Minneapolis property of denying rooms to ICE agents, prompting swift corporate response and policy reaffirmation. Hawaiian Electric (HE) agreed to a $47.75M shareholder settlement over claims of misrepresenting wildfire safety measures prior to the 2023 Maui disaster.

Seeking Alpha • Jan 6, 2026

Nissan Selects IPfolio from Clarivate

Managing IP with advanced workflow automation technology and leading data LONDON , Dec. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Nissan Motor Co., Ltd (Nissan: 7201.T) has selected IPfolio. This intellectual property management software (IPMS) will help Nissan manage and protect its IP more efficiently with advanced workflow automation technology and world-leading data and analytics.

PRNewsWire • Dec 18, 2025

Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance

Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product lifecycle LONDON , Dec. 4, 2025 /PRNewswire/ -- Clarivate Plc  (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its Cortellis Regulatory Intelligence AI Assistant. Powered by agentic AI, the assistant introduces new capabilities that redefine how life sciences professionals access and apply regulatory information.

PRNewsWire • Dec 4, 2025

Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI

New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom to operate, patentability, and infringement related decisions LONDON , Nov. 24, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of Derwent Patent Monitor to streamline intellectual property (IP) and research and development (R&D) collaborative patent reviews when determining patentability, assessing freedom to operate (FTO) and evaluating opposition or assertion. Built with proprietary data, Derwent Patent Monitor offers AI-powered evaluation of potential threats helping to accelerate first-pass reviews (Threat Analysis) to surface the most critical risks for stakeholders.

PRNewsWire • Nov 24, 2025

Clarivate Plc (CLVT) Presents at Global Technology, Internet, Media & Telecommunications Conference 2025 Transcript

Clarivate Plc ( CLVT ) Global Technology, Internet, Media & Telecommunications Conference 2025 November 19, 2025 1:20 PM EST Company Participants Matti Shem Tov - CEO & Director Jonathan Collins - Executive VP & CFO Conference Call Participants Ashish Sabadra - RBC Capital Markets, Research Division Presentation Ashish Sabadra RBC Capital Markets, Research Division Sabadra, and I cover information services companies here at RBC. Matti -- we are excited to host Matti, CEO; and Jonathan CFO of Clarivate.

Seeking Alpha • Nov 19, 2025

Clarivate to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on November 19

LONDON , Nov. 13, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Matt Shem Tov, Chief Executive Officer, and Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference, on Wednesday, November 19, 2025 at 1:20 pm Eastern Time. The live webcast can be accessed at https://kvgo.com/rbc-2025-global-tech/clarivate-november-2025 and will be available for replay.

PRNewsWire • Nov 13, 2025

Clarivate Announces Highly Cited Researchers 2025 List

Celebrating exceptional, community-wide excellence, based on rigorous evaluation and selection LONDON , Nov. 12, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Highly Cited Researchers 2025 list. This annual list recognizes researchers whose contributions have demonstrated broad and significant influence in their fields.

PRNewsWire • Nov 12, 2025

Is Clarivate Stock a Buy After a Member of the Board of Directors Bought Shares for $2.5 Million?

Kenneth L. Cornick, a member of the Board of Directors for Clarivate, purchased 725,000 shares in the company. The purchase came a few days after Clarivate reported third quarter results on Oct. 29.

The Motley Fool • Nov 8, 2025

Fujifilm Selects IPfolio from Clarivate

Maximizing the value of intellectual property assets to support business growth LONDON , Nov. 6, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that FUJIFILM Holdings Corporation (Fujifilm: 4901.T) has selected IPfolio, the premier Clarivate cloud-based intellectual property (IP) management platform. This solution will support Fujifilm, which operates a diverse range of global businesses in healthcare, electronics, business innovation, and imaging, to maximize the efficiency of its IP operations and drive business growth.

PRNewsWire • Nov 6, 2025